These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31143935)

  • 1. Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.
    Yang Y; Wu L; Shu XO; Cai Q; Shu X; Li B; Guo X; Ye F; Michailidou K; Bolla MK; Wang Q; Dennis J; Andrulis IL; Brenner H; Chenevix-Trench G; Campa D; Castelao JE; Gago-Dominguez M; Dörk T; Hollestelle A; Lophatananon A; Muir K; Neuhausen SL; Olsson H; Sandler DP; Simard J; Kraft P; Pharoah PDP; Easton DF; Zheng W; Long J
    J Natl Cancer Inst; 2020 Mar; 112(3):295-304. PubMed ID: 31143935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.
    Yang Y; Wu L; Shu X; Lu Y; Shu XO; Cai Q; Beeghly-Fadiel A; Li B; Ye F; Berchuck A; Anton-Culver H; Banerjee S; Benitez J; Bjørge L; Brenton JD; Butzow R; Campbell IG; Chang-Claude J; Chen K; Cook LS; Cramer DW; deFazio A; Dennis J; Doherty JA; Dörk T; Eccles DM; Edwards DV; Fasching PA; Fortner RT; Gayther SA; Giles GG; Glasspool RM; Goode EL; Goodman MT; Gronwald J; Harris HR; Heitz F; Hildebrandt MA; Høgdall E; Høgdall CK; Huntsman DG; Kar SP; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Koushik A; Lambrechts D; Le ND; Levine DA; Massuger LF; Matsuo K; May T; McNeish IA; Menon U; Modugno F; Monteiro AN; Moorman PG; Moysich KB; Ness RB; Nevanlinna H; Olsson H; Onland-Moret NC; Park SK; Paul J; Pearce CL; Pejovic T; Phelan CM; Pike MC; Ramus SJ; Riboli E; Rodriguez-Antona C; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Shan K; Siddiqui N; Sieh W; Stampfer MJ; Sutphen R; Swerdlow AJ; Szafron LM; Teo SH; Tworoger SS; Tyrer JP; Webb PM; Wentzensen N; White E; Willett WC; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
    Cancer Res; 2019 Feb; 79(3):505-517. PubMed ID: 30559148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
    Zhao X; Yang M; Fan J; Wang M; Wang Y; Qin N; Zhu M; Jiang Y; Gorlova OY; Gorlov IP; Albanes D; Lam S; Tardón A; Chen C; Goodman GE; Bojesen SE; Landi MT; Johansson M; Risch A; Wichmann HE; Bickeböller H; Christiani DC; Rennert G; Arnold SM; Brennan P; Field JK; Shete S; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Woll PJ; Lazarus P; Schabath MB; Aldrich MC; Patel AV; Davies MPA; Ma H; Jin G; Hu Z; Amos CI; Shen H; Dai J
    Cancer; 2024 Mar; 130(6):913-926. PubMed ID: 38055287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.
    Song MA; Brasky TM; Marian C; Weng DY; Taslim C; Dumitrescu RG; Llanos AA; Freudenheim JL; Shields PG
    Epigenetics; 2015; 10(12):1177-87. PubMed ID: 26680018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study.
    Xu Z; Sandler DP; Taylor JA
    J Natl Cancer Inst; 2020 Jan; 112(1):87-94. PubMed ID: 30989176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk.
    Zhu J; Yang Y; Kisiel JB; Mahoney DW; Michaud DS; Guo X; Taylor WR; Shu XO; Shu X; Liu D; Li B; Tao R; Cai Q; Zheng W; Long J; Wu L
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2079-2087. PubMed ID: 34497089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D, DNA methylation, and breast cancer.
    O'Brien KM; Sandler DP; Xu Z; Kinyamu HK; Taylor JA; Weinberg CR
    Breast Cancer Res; 2018 Jul; 20(1):70. PubMed ID: 29996894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
    Liu X; Peng Y; Wang J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.
    Bodelon C; Ambatipudi S; Dugué PA; Johansson A; Sampson JN; Hicks B; Karlins E; Hutchinson A; Cuenin C; Chajès V; Southey MC; Romieu I; Giles GG; English D; Polidoro S; Assumma M; Baglietto L; Vineis P; Severi G; Herceg Z; Flanagan JM; Milne RL; Garcia-Closas M
    Breast Cancer Res; 2019 May; 21(1):62. PubMed ID: 31101124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
    de Almeida BP; Apolónio JD; Binnie A; Castelo-Branco P
    BMC Cancer; 2019 Mar; 19(1):219. PubMed ID: 30866861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.
    Guo Y; Warren Andersen S; Shu XO; Michailidou K; Bolla MK; Wang Q; Garcia-Closas M; Milne RL; Schmidt MK; Chang-Claude J; Dunning A; Bojesen SE; Ahsan H; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bogdanova NV; Bonanni B; Børresen-Dale AL; Brand J; Brauch H; Brenner H; Brüning T; Burwinkel B; Casey G; Chenevix-Trench G; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Dumont M; Fasching PA; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Fostira F; Gammon M; Giles GG; Guénel P; Haiman CA; Hamann U; Hooning MJ; Hopper JL; Jakubowska A; Jasmine F; Jenkins M; John EM; Johnson N; Jones ME; Kabisch M; Kibriya M; Knight JA; Koppert LB; Kosma VM; Kristensen V; Le Marchand L; Lee E; Li J; Lindblom A; Luben R; Lubinski J; Malone KE; Mannermaa A; Margolin S; Marme F; McLean C; Meijers-Heijboer H; Meindl A; Neuhausen SL; Nevanlinna H; Neven P; Olson JE; Perez JI; Perkins B; Peterlongo P; Phillips KA; Pylkäs K; Rudolph A; Santella R; Sawyer EJ; Schmutzler RK; Seynaeve C; Shah M; Shrubsole MJ; Southey MC; Swerdlow AJ; Toland AE; Tomlinson I; Torres D; Truong T; Ursin G; Van Der Luijt RB; Verhoef S; Whittemore AS; Winqvist R; Zhao H; Zhao S; Hall P; Simard J; Kraft P; Pharoah P; Hunter D; Easton DF; Zheng W
    PLoS Med; 2016 Aug; 13(8):e1002105. PubMed ID: 27551723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
    Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating muti-omics data to identify tissue-specific DNA methylation biomarkers for cancer risk.
    Yang Y; Chen Y; Xu S; Guo X; Jia G; Ping J; Shu X; Zhao T; Yuan F; Wang G; Xie Y; Ci H; Liu H; Qi Y; Liu Y; Liu D; Li W; Ye F; Shu XO; Zheng W; Li L; Cai Q; Long J
    Nat Commun; 2024 Jul; 15(1):6071. PubMed ID: 39025880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An epigenome-wide study of body mass index and DNA methylation in blood using participants from the Sister Study cohort.
    Wilson LE; Harlid S; Xu Z; Sandler DP; Taylor JA
    Int J Obes (Lond); 2017 Jan; 41(1):194-199. PubMed ID: 27773939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers.
    Sathyanarayanan A; Tanha HM; Mehta D; Nyholt DR
    Commun Biol; 2022 Jun; 5(1):594. PubMed ID: 35710732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.
    Zheng W; Wen W; Gao YT; Shyr Y; Zheng Y; Long J; Li G; Li C; Gu K; Cai Q; Shu XO; Lu W
    J Natl Cancer Inst; 2010 Jul; 102(13):972-81. PubMed ID: 20484103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients.
    Lee NY; Hum M; Tan GP; Seah AC; Ong PY; Kin PT; Lim CW; Samol J; Tan NC; Law HY; Tan MH; Lee SC; Ang P; Lee ASG
    Clin Epigenetics; 2024 May; 16(1):66. PubMed ID: 38750495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenome-wide association study of breast cancer using prospectively collected sister study samples.
    Xu Z; Bolick SC; DeRoo LA; Weinberg CR; Sandler DP; Taylor JA
    J Natl Cancer Inst; 2013 May; 105(10):694-700. PubMed ID: 23578854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose.
    Chung RH; Chiu YF; Wang WC; Hwu CM; Hung YJ; Lee IT; Chuang LM; Quertermous T; Rotter JI; Chen YI; Chang IS; Hsiung CA
    Diabetologia; 2021 Jul; 64(7):1613-1625. PubMed ID: 33842983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.